Holocene Advisors’s Gilead Sciences GILD Stock Holding History

Holocene Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$406M	Buy	3,216,892 +605,066	+23%	+$79.7M	0.92%	17
2026 Q1	$364M	Sell	2,611,826 -1,552,612	-37%	-$217M	0.88%	22
2025 Q4	$511M	Buy	4,164,438 +1,547,266	+59%	+$188M	1.07%	10
2025 Q3	$291M	Sell	2,617,172 -1,609,799	-38%	-$183M	0.66%	40
2025 Q2	$469M	Buy	4,226,971 +1,919,100	+83%	+$204M	1.14%	11
2025 Q1	$259M	Buy	+2,307,871	New	+$238M	0.75%	33
2022 Q2	–	Sell	-25,713	Closed	-$1.53M	–	891
2022 Q1	$1.53M	Buy	+25,713	New	+$1.64M	0.01%	599
2021 Q2	–	Sell	-2,038,262	Closed	-$132M	–	872
2021 Q1	$132M	Buy	2,038,262 +811,897	+66%	+$52.4M	0.83%	24
2020 Q4	$71.4M	Buy	+1,226,365	New	+$74M	0.45%	69
2018 Q2	–	Sell	-3,316	Closed	-$250K	–	626
2018 Q1	$250K	Sell	3,316 -6,127	-65%	-$487K	0.01%	445
2017 Q4	$676K	Buy	+9,443	New	+$717K	0.02%	320

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Holocene Advisors's GILD Position: Q2 2026 in Review

Holocene Advisors increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $79.7M and bringing the position to 3,216,892 shares worth $406M. The position accounts for 0.92% of the portfolio, ranked #17.

Holocene Advisors first reported a position in GILD in Q4 2017 and has held it in 11 quarters since. The position peaked at $511M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Holocene Advisors held 3,216,892 shares of Gilead Sciences worth $406M as of Q2 2026.
Holocene Advisors bought 605,066 Gilead Sciences shares in Q2 2026, an estimated $79.7M.
Gilead Sciences made up 0.92% of Holocene Advisors's portfolio in Q2 2026, its #17 holding.
Holocene Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 11 quarters since.
Holocene Advisors's Gilead Sciences position peaked at $511M in Q4 2025.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.